The ω-3 Polyunsaturated Fatty Acid, Eicosapentaenoic Acid, Attenuates Abdominal Aortic Aneurysm Development via Suppression of Tissue Remodeling
暂无分享,去创建一个
I. Komuro | K. Fujiu | R. Nagai | I. Manabe | K. Eguchi | Jackson Wang | S. Matsumoto | Sahohime Matsumoto
[1] J. Lindholt,et al. Randomized double‐blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion , 2001, The British journal of surgery.
[2] S. Watkins,et al. GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects , 2010, Cell.
[3] Timothy C Greiner,et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. , 2002, The Journal of clinical investigation.
[4] U. P. S. T. Force,et al. Screening for Abdominal Aortic Aneurysm: Recommendation Statement , 2005, Annals of Internal Medicine.
[5] T. Kadowaki,et al. Saturated fatty acid and TLR signaling link β cell dysfunction and islet inflammation. , 2012, Cell metabolism.
[6] Peter Libby,et al. Inflammation and cellular immune responses in abdominal aortic aneurysms. , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[7] R. Morishita,et al. Pharmacological treatment of abdominal aortic aneurysm. , 2009, Cardiovascular research.
[8] K. Bønaa,et al. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study. , 1990, The New England journal of medicine.
[9] J. H. van Bockel,et al. A Clinical Evaluation of Statin Pleiotropy: Statins Selectively and Dose-Dependently Reduce Vascular Inflammation , 2013, PloS one.
[10] J. H. van Bockel,et al. Clinical Trial of Doxycycline for Matrix Metalloproteinase-9 Inhibition in Patients With an Abdominal Aneurysm: Doxycycline Selectively Depletes Aortic Wall Neutrophils and Cytotoxic T Cells , 2009, Circulation.
[11] M. Leinonen,et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. , 2001, Journal of vascular surgery.
[12] Y. Matsuzawa,et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.
[13] B. Coll,et al. RANKL Increases Vascular Smooth Muscle Cell Calcification Through a RANK-BMP4–Dependent Pathway , 2009, Circulation research.
[14] Y. Tintut,et al. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. , 2006, Circulation research.
[15] E. Bergstralh,et al. A controlled trial of fish oil in IgA nephropathy. Mayo Nephrology Collaborative Group. , 1994, The New England journal of medicine.
[16] N. Weintraub,et al. Understanding abdominal aortic aneurysm. , 2009, The New England journal of medicine.
[17] W. Pearce,et al. Murine aortic aneurysm produced by periarterial application of calcium chloride. , 2001, The Journal of surgical research.
[18] Lois E. H. Smith,et al. Increased dietary intake of ω-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis , 2007, Nature Medicine.
[19] Cheng Zhang,et al. Activation of AMP-activated protein kinase α2 by nicotine instigates formation of abdominal aortic aneurysms in mice in vivo , 2012, Nature Medicine.
[20] K. Fujiu,et al. Renal collecting duct epithelial cells regulate inflammation in tubulointerstitial damage in mice. , 2011, The Journal of clinical investigation.
[21] K. Mayer,et al. Correction: n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysis , 2012, Critical Care.
[22] W. Harris,et al. Omega-3 Fatty Acids Prevent Pressure Overload–Induced Cardiac Fibrosis Through Activation of Cyclic GMP/Protein Kinase G Signaling in Cardiac Fibroblasts , 2011, Circulation.
[23] J. Mactaggart,et al. Blocking TNF-α Attenuates Aneurysm Formation in a Murine Model1 , 2009, The Journal of Immunology.
[24] P. Calder,et al. Cardiovascular effects of marine omega-3 fatty acids , 2010, The Lancet.
[25] C. Munaut,et al. TIMP-2 and PAI-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. , 2003, Cardiovascular research.
[26] J. Semmens,et al. Falling rates of hospitalization and mortality from abdominal aortic aneurysms in Australia. , 2011, Journal of vascular surgery.
[27] C. Beeton,et al. Detection of Functional Matrix Metalloproteinases by Zymography , 2010, Journal of visualized experiments : JoVE.
[28] Lawrence J Appel,et al. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[29] Charles N. Serhan,et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes , 2007, Nature.
[30] R. Ricci,et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase , 2005, Nature Medicine.
[31] R. Visse,et al. This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .
[32] L. Robertson,et al. Medical treatment for small abdominal aortic aneurysms. , 2012, The Cochrane database of systematic reviews.
[33] B. Baxter,et al. Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. , 1998, Arteriosclerosis, thrombosis, and vascular biology.
[34] R. Levine,et al. Mitral Valve Endothelial Cells With Osteogenic Differentiation Potential , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[35] P. Libby,et al. Arterial and Aortic Valve Calcification Abolished by Elastolytic Cathepsin S Deficiency in Chronic Renal Disease , 2009, Circulation.
[36] S. Shapiro,et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. , 2000, The Journal of clinical investigation.
[37] L. Tavazzi,et al. ect of n-3 polyunsaturated fatty acids in patients with chronic heart failure ( the GISSI-HF trial ) : a randomised , double-blind , placebo-controlled trial , 1980 .
[38] Y. Tintut,et al. N-3 Fatty Acids Inhibit Vascular Calcification Via the p38-Mitogen-Activated Protein Kinase and Peroxisome Proliferator-Activated Receptor-γ Pathways , 2006 .
[39] Yong Sun,et al. Runx2-Upregulated Receptor Activator of Nuclear Factor &kgr;B Ligand in Calcifying Smooth Muscle Cells Promotes Migration and Osteoclastic Differentiation of Macrophages , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[40] T. Greiner,et al. Key Roles of CD4+ T Cells and IFN-γ in the Development of Abdominal Aortic Aneurysms in a Murine Model1 , 2004, The Journal of Immunology.
[41] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[42] P. Calder,et al. Omega-3 Fatty Acids and Inflammation: Novel Interactions Reveal a New Step in Neutrophil Recruitment , 2009, PLoS biology.
[43] A Daugherty,et al. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.
[44] R. Cohan,et al. Abdominal aortic aneurysm morphology: CT features in patients with ruptured and nonruptured aneurysms. , 1994, AJR. American journal of roentgenology.
[45] J. Golledge,et al. The calcium chloride-induced rodent model of abdominal aortic aneurysm. , 2013, Atherosclerosis.
[46] R. Nagai,et al. Orally administered eicosapentaenoic acid reduces and stabilizes atherosclerotic lesions in ApoE-deficient mice. , 2008, Atherosclerosis.
[47] I. Komuro,et al. Saturated Fatty Acid Palmitate Aggravates Neointima Formation by Promoting Smooth Muscle Phenotypic Modulation , 2013, Arteriosclerosis, thrombosis, and vascular biology.
[48] P. Collin‐Osdoby. Regulation of Vascular Calcification by Osteoclast Regulatory Factors RANKL and Osteoprotegerin , 2004, Circulation research.
[49] R. Mecham,et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. , 1995, The Journal of clinical investigation.
[50] G. Ailawadi,et al. Neutrophil Depletion Inhibits Experimental Abdominal Aortic Aneurysm Formation , 2005, Circulation.
[51] É. Allaire,et al. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. , 1998, The Journal of clinical investigation.
[52] Y. Kamei,et al. Increased Adiponectin Secretion by Highly Purified Eicosapentaenoic Acid in Rodent Models of Obesity and Human Obese Subjects , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[53] H. J. Kim,et al. Omega-3 fatty acid supplementation attenuates oxidative stress, inflammation, and tubulointerstitial fibrosis in the remnant kidney. , 2009, American journal of physiology. Renal physiology.
[54] E. Liao,et al. RANKL Is a Downstream Mediator for Insulin-Induced Osteoblastic Differentiation of Vascular Smooth Muscle Cells , 2010, PloS one.
[55] L. A. Anderson. Abdominal aortic aneurysm. , 2001, The Journal of cardiovascular nursing.